Bonk (NASDAQ:BNKK – Get Free Report) issued its earnings results on Wednesday. The company reported ($0.11) earnings per share for the quarter, Zacks reports. The company had revenue of $1.51 million during the quarter.
Bonk Stock Performance
Shares of Bonk stock opened at $0.17 on Friday. Bonk has a 52 week low of $0.13 and a 52 week high of $1.34.
Analyst Ratings Changes
Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Bonk in a research note on Wednesday. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has a consensus rating of “Sell”.
Bonk Company Profile
Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema.
Recommended Stories
- Five stocks we like better than Bonk
- Which Wall Street Analysts are the Most Accurate?
- 3 Big Tech Stocks Sliding: What’s Behind the Drop?
- How to trade using analyst ratings
- Wall Street Sees a Winner in Take-Two Stock. Should You?
- What Are Treasury Bonds?
- Datavault AI Just Raised Guidance by 400%—Are You Paying Attention?
Receive News & Ratings for Bonk Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bonk and related companies with MarketBeat.com's FREE daily email newsletter.
